首页> 外国专利> SURVIVAL AND DEATH SPECIFIC BIOMARKER FOR DETERMINING PROGNOSIS AND TREATMENT STRATEGY IN PATIENTS WITH LUNG ADENOCARCINOMA

SURVIVAL AND DEATH SPECIFIC BIOMARKER FOR DETERMINING PROGNOSIS AND TREATMENT STRATEGY IN PATIENTS WITH LUNG ADENOCARCINOMA

机译:用于确定肺腺癌患者预后和治疗策略的生存和死亡生物标志物

摘要

The present invention relates to a marker for determining prognosis of patients with lung adenocarcinoma. In the patients with the lung adenocarcinoma, since the mutation of a gene of the present invention and the survival rate of a patient, or the mutation of a gene of the present invention and the recurrence rate of the lung adenocarcinoma are related to each other, variants of the genes of the present invention can be used as markers in predicting the prognosis of patients with the lung adenocarcinoma.;COPYRIGHT KIPO 2018
机译:本发明涉及用于确定肺腺癌患者的预后的标志物。在患有肺腺癌的患者中,由于本发明的基因的突变与患者的存活率或本发明的基因的突变与肺腺癌的复发率相关,本发明基因的变体可用作预测肺腺癌患者预后的标志物; COPYRIGHT KIPO 2018

著录项

  • 公开/公告号KR20180092908A

    专利类型

  • 公开/公告日2018-08-20

    原文格式PDF

  • 申请/专利权人 CHO HAN JUN;

    申请/专利号KR20180085078

  • 发明设计人 CHO HAN JUNKR;

    申请日2018-07-21

  • 分类号C12Q1/6886;

  • 国家 KR

  • 入库时间 2022-08-21 12:39:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号